UP!

CVRS $4.27   View long term graphs

Corindus Vascular Robotics (Corindus, Inc.) was founded in 2002 by Rafael Beyar, an interventional cardiologist, and Tal Wenderow. Its goal is to use remote control and robotics to move coronary guidewires and balloon/stent catheters.

Corindus, Inc. is based in Waltham, Massachusetts. The company’s FDA-cleared CorPath® System is the first medical device that allows interventional cardiologists to manipulate guidewires and balloon/stents from an interventional cockpit.

The company went public in August 2014 and currently trades on the New York Stock Exchange with the ticker symbol CVRS.


News

Corindus Vascular Robotics, Inc. (healthcare)

Q reports

Period Date Adjusted Actuals EPS GAAP EPS

Ratings

2016-04-20 Reiterated Rating Sterne Agee CRT Buy $3.00
2016-01-19 Lower Price Target Stifel Nicolaus Buy $6.00 to $4.00
2015-06-23 Initiated Coverage Cowen and Company Outperform $5.25
2015-06-23 Initiated Coverage Stifel Nicolaus Buy $6.00
2016-04-20 Reiterated Rating Sterne Agee CRT Buy $3.00
2016-01-19 Lower Price Target Stifel Nicolaus Buy $6.00 to $4.00
2015-06-23 Initiated Coverage Cowen and Company Outperform $5.25
2015-06-23 Initiated Coverage Stifel Nicolaus Buy $6.00

There is presents forecasts of rating agencies and recommendations for investors about this ticker

Major Shareholders

Name Relationship Total Shares Holding stocks

Comments